IPO Monitor: Latest IPO News (beta)

[ All Markets | U.S. | Canada | Europe | China ]

China probes alleged fraud at Luckin Coffee, banks review IPO work

China's securities regulator said on Friday it would investigate claims of fraud at Luckin Coffee Inc (LK) and sources said some of the banks involved in the Chinese chain's successful U.S. IPO last year were reviewing their work in the listing.
[ Fidelity at 2020-04-03 03:55:04 ]

China probing alleged fraud at Luckin Coffee, banks review IPO work

China's securities regulator said on Friday it would investigate claims of fraud at Luckin Coffee Inc (LK), and sources said some of the banks involved in the Chinese chain's successful U.S. IPO last year were reviewing their work in the listing.
[ Fidelity at 2020-04-03 02:00:08 ]

BRIEF-Zentalis Pharmaceuticals Announces Pricing Of Initial Public Offering

Zentalis Pharmaceuticals LLC: * ZENTALIS PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING. * SAYS INITIAL PUBLIC OFFERING OF 9.18 MILLION COMMON SHARES PRICED AT $18.00PER SHARE. * COMMON STOCK EXPECTED TO BEGIN TRADING ON NASDAQ GLOBAL MARKET ON APRIL 3, UNDER TICKER SYMBOL "ZNTL" Source text for Eikon: Further company coverage:
[ Fidelity at 2020-04-02 18:28:23 ]

Zentalis Pharmaceuticals Announces Pricing of Initial Public Offering

[ GlobeNewswire at 2020-04-02 18:22:00 ]

No School? Use Pocket Change to Help Educate Children at Home

National Coin Week, April 19-25, emphasizes that money is history you can hold in your hands
[ GlobeNewswire at 2020-04-01 12:08:00 ]

BRIEF-Keros Therapeutics Sees IPO Of Up To 5 Million Shares

Keros Therapeutics Inc: * KEROS THERAPEUTICS INC SEES IPO OF UP TO 5.0 MILLION SHARES PRICED BETWEEN $14.00 AND $16.00 PER SHARE - SEC FILING. * KEROS THERAPEUTICS INC SAYS INTENDS TO USE ABOUT $8.1 MILLION OF IPO PROCEEDS TO ADVANCE CLINICAL DEVELOPMENT OF KER-050. * KEROS THERAPEUTICS INC SAYS INTENDS TO USE ABOUT $13.1 MILLION OF IPO PROCEEDS TO ADVANCE CLINICAL DEVELOPMENT OF KER-047.
[ Fidelity at 2020-04-01 03:38:41 ]

Keros Therapeutics sets IPO terms, expects to raise up to $80 million

Keros Therapeutics has set terms of its initial public offering, in which it expects to raise up to $80 million, and be valued at about $291 million. The biopharmaceutical company, which is developing treatments for hematological and musculoskeletal disorders, if offering 5 million shares for sale with the IPO expected to price between $14 and $16 a share. The stock is expected to be listed on the Nasdaq exchange under the ticker symbol "KROS."
[ Fidelity at 2020-04-01 03:32:16 ]

BRIEF-Wimi Hologram Cloud Inc Announces Pricing Of Initial Public Offering

WiMi Hologram Cloud Inc: * WIMI HOLOGRAM CLOUD INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING. * WIMI HOLOGRAM CLOUD INC SAYS PRICING OF WIMI'S UNDERWRITTEN INITIAL PUBLIC OFFERING OF 4.75 MILLION AMERICAN DEPOSITARY SHARES AT US$5.50 PER ADS Source text for Eikon: Further company coverage:
[ Fidelity at 2020-03-31 21:47:33 ]

BRIEF-Harbor Custom Development Files For Firm Commitment IPO Of Shares Of Common Stock Of Co

Harbor Custom Development: * HARBOR CUSTOM DEVELOPMENT, INC FILES FOR FIRM COMMITMENT IPO OF SHARES OF COMMON STOCK OF CO. * HARBOR CUSTOM DEVELOPMENT, INC - INTEND TO APPLY TO LIST THE SHARES OF COMMON STOCK ON THE NYSE AMERICAN UNDER THE SYMBOL ÂHCD. * HARBOR CUSTOM DEVELOPMENT, INC SAYS THINKEQUITY IS UNDERWRITERS TO IPO Source:
[ Fidelity at 2020-03-31 15:12:13 ]

Crown Castle Announces Proposed Offering of Senior Notes

[ GlobeNewswire at 2020-03-31 05:41:00 ]

EdtechX Holdings (NASDAQ:EDTX) and Meten International Announce Successful Merger Closing and Capital Raise

[ GlobeNewswire at 2020-03-30 12:25:00 ]

BRIEF-Zentalis Pharmaceuticals Sees IPO Of Up To 7.65 Mln Shares

ZENTALIS PHARMACEUTICALS : * ZENTALIS PHARMACEUTICALS LLC SEES IPO OF UP TO 7.65 MILLION SHARES OF COMMON STOCK PRICED TO BE BETWEEN $16.00 AND $18.00 PER SHARE - SEC FILING Source:
[ Fidelity at 2020-03-30 04:55:13 ]

Zentalis Pharmaceuticals sets IPO terms, to be valued at up to $592 million

Zentalis Pharmaceuticals set terms of its initial public offering, in which the biopharmaceutical company developing cancer treatments is expected to raise up to $137.7 million. Zentalis is offering 7.65 million shares in the IPO, which is expected to price between $16 and $18 a share. That would give the company a market capitalization of up to $591.7 million.
[ Fidelity at 2020-03-30 03:53:31 ]

Shanghai tops world's IPO league table despite coronavirus

Shanghai has topped global initial public offering league table for the first time in nearly three years, even as the coronavirus epidemic which originated in China rocked markets around the world.
[ Fidelity at 2020-03-29 18:31:59 ]

BRIEF-Loha Co Says Sees U.S. IPO Of Up To 4.3 Mln Class A Ordinary Shares Priced To Be Between $5.00 And $7.00 Per ...

* LOHA CO LTD SAYS SEES U.S. IPO OF UP TO 4.3 MILLION CLASS A ORDINARY SHARES PRICED TO BE BETWEEN $5.00 AND $7.00 PER SHARE - SEC FILING. * LOHA CO LTD SAYS IT ADDS TIGER BROKERS, VALUABLE CAPITAL AND PRIME NUMBER CAPITAL ARE TO THE UNDERWRITERS TO THE IPO Source : Further company coverage: [ ]
[ Fidelity at 2020-03-27 14:41:08 ]

BRIEF-Hitek Global Sees U.S. IPO Of Up To 4.0 Mln Ordinary Shares Priced To Be Between $4 And $6 Per Share - SEC Filing

Hitek Global Inc.: * HITEK GLOBAL INC SAYS NOW SEES U.S. IPO OF UP TO 4.0 MILLION ORDINARY SHARES PRICED TO BE BETWEEN $4 AND $6 PER ORDINARY SHARE - SEC FILING. * HITEK GLOBAL INC SAYS IT HAD PREVIOUSLY EXPECTED U.S. IPO OF UP TO 3.0 MILLION ORDINARY SHARES PRICED TO BE BETWEEN $4 AND $6 PER ORDINARY SHARE Source : Further company coverage:
[ Fidelity at 2020-03-26 14:38:20 ]

BRIEF-Gan Limited Files For U.S. IPO Of Up To $35 Million

Gan Limited: * GAN LIMITED FILES FOR U.S. IPO OF UP TO $35 MILLION ORDINARY SHARES Â SEC FILING. * GAN LIMITED - HAVE APPLIED FOR LISTING OF ORDINARY SHARES ON THE NASDAQ CAPITAL MARKET UNDER THE SYMBOL ÂGAN. * GAN LIMITED - SAYS B. RILEY FBR IS UNDERWRITER TO IPO. * GAN LIMITED - PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR PURPOSE OF CALCULATING SEC REGISTRATION FEE Source text:
[ Fidelity at 2020-03-25 10:01:32 ]

SUSTAINABLE INFRASTRUCTURE DIVIDEND FUND IPO Raises $80 Million

[ GlobeNewswire at 2020-03-25 06:14:00 ]

Prudential Says Looking at Other Options Besides Minority IPO for Jackson Business; Shares Gain

Shares of Prudential were up Tuesday morning after the insurance giant said it was considering other options besides a minority initial public offering for its US business, Jackson National Life, due to continued market turmoil caused by the ongoing COVID-19 pandemic. Earlier this month, the company said it was looking to float a minority stake in Jackson.
[ Fidelity at 2020-03-24 06:41:37 ]

BRIEF-Aura Announces Postponement Of Plans For Initial Public Offering And Listing In Brazil Amid COVID-19 Impact

Aura Minerals Inc(ARMZF): * AURA ANNOUNCES POSTPONEMENT OF PLANS FOR INITIAL PUBLIC OFFERING AND LISTING IN BRAZIL AMID COVID-19 IMPACT. * Aura Minerals Inc(ARMZF) - WILL REASSESS MARKET CONDITIONS IN SECOND HALF OF 2020. * Aura Minerals Inc (ARMZF) - DECIDED TO POSTPONE INITIAL PUBLIC OFFERING IN BRAZIL AND CONCURRENT LISTING OF BRAZILIAN DEPOSITARY RECEIPTS ON B3 S.A. Source text for Eikon: Further company coverage:
[ Fidelity at 2020-03-24 05:39:33 ]

More IPO News >>



Initial Public Offerings IPO News (beta) Recent Filings IPO Calendar Recent Pricings IPO Withdrawals Quiet Period Deal Flow Lockup Expirations Best-Worst Performers Industry Analysis Underwriter Performance Quarterly Reviews Secondary Offerings Recent Filings Calendar Recent Pricings Quiet Period Deal Flow Best-Worst Performers Industry Analysis Underwriter Performance Quarterly Reviews Tools Search Recent Events Underwriters Aftermarket Report	Latest IPO News (beta) [ All Markets \| U.S. \| Canada \| Europe \| China ] China probes alleged fraud at Luckin Coffee, banks review IPO work China's securities regulator said on Friday it would investigate claims of fraud at Luckin Coffee Inc (LK) and sources said some of the banks involved in the Chinese chain's successful U.S. IPO last year were reviewing their work in the listing. [ Fidelity at 2020-04-03 03:55:04 ] China probing alleged fraud at Luckin Coffee, banks review IPO work China's securities regulator said on Friday it would investigate claims of fraud at Luckin Coffee Inc (LK), and sources said some of the banks involved in the Chinese chain's successful U.S. IPO last year were reviewing their work in the listing. [ Fidelity at 2020-04-03 02:00:08 ] BRIEF-Zentalis Pharmaceuticals Announces Pricing Of Initial Public Offering Zentalis Pharmaceuticals LLC: * ZENTALIS PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING. * SAYS INITIAL PUBLIC OFFERING OF 9.18 MILLION COMMON SHARES PRICED AT $18.00PER SHARE. * COMMON STOCK EXPECTED TO BEGIN TRADING ON NASDAQ GLOBAL MARKET ON APRIL 3, UNDER TICKER SYMBOL "ZNTL" Source text for Eikon: Further company coverage: [ Fidelity at 2020-04-02 18:28:23 ] Zentalis Pharmaceuticals Announces Pricing of Initial Public Offering [ GlobeNewswire at 2020-04-02 18:22:00 ] No School? Use Pocket Change to Help Educate Children at Home National Coin Week, April 19-25, emphasizes that money is history you can hold in your hands [ GlobeNewswire at 2020-04-01 12:08:00 ] BRIEF-Keros Therapeutics Sees IPO Of Up To 5 Million Shares Keros Therapeutics Inc: * KEROS THERAPEUTICS INC SEES IPO OF UP TO 5.0 MILLION SHARES PRICED BETWEEN $14.00 AND $16.00 PER SHARE - SEC FILING. * KEROS THERAPEUTICS INC SAYS INTENDS TO USE ABOUT $8.1 MILLION OF IPO PROCEEDS TO ADVANCE CLINICAL DEVELOPMENT OF KER-050. * KEROS THERAPEUTICS INC SAYS INTENDS TO USE ABOUT $13.1 MILLION OF IPO PROCEEDS TO ADVANCE CLINICAL DEVELOPMENT OF KER-047. [ Fidelity at 2020-04-01 03:38:41 ] Keros Therapeutics sets IPO terms, expects to raise up to $80 million Keros Therapeutics has set terms of its initial public offering, in which it expects to raise up to $80 million, and be valued at about $291 million. The biopharmaceutical company, which is developing treatments for hematological and musculoskeletal disorders, if offering 5 million shares for sale with the IPO expected to price between $14 and $16 a share. The stock is expected to be listed on the Nasdaq exchange under the ticker symbol "KROS." [ Fidelity at 2020-04-01 03:32:16 ] BRIEF-Wimi Hologram Cloud Inc Announces Pricing Of Initial Public Offering WiMi Hologram Cloud Inc: * WIMI HOLOGRAM CLOUD INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING. * WIMI HOLOGRAM CLOUD INC SAYS PRICING OF WIMI'S UNDERWRITTEN INITIAL PUBLIC OFFERING OF 4.75 MILLION AMERICAN DEPOSITARY SHARES AT US$5.50 PER ADS Source text for Eikon: Further company coverage: [ Fidelity at 2020-03-31 21:47:33 ] BRIEF-Harbor Custom Development Files For Firm Commitment IPO Of Shares Of Common Stock Of Co Harbor Custom Development: * HARBOR CUSTOM DEVELOPMENT, INC FILES FOR FIRM COMMITMENT IPO OF SHARES OF COMMON STOCK OF CO. * HARBOR CUSTOM DEVELOPMENT, INC - INTEND TO APPLY TO LIST THE SHARES OF COMMON STOCK ON THE NYSE AMERICAN UNDER THE SYMBOL ÂHCD. * HARBOR CUSTOM DEVELOPMENT, INC SAYS THINKEQUITY IS UNDERWRITERS TO IPO Source: [ Fidelity at 2020-03-31 15:12:13 ] Crown Castle Announces Proposed Offering of Senior Notes [ GlobeNewswire at 2020-03-31 05:41:00 ] EdtechX Holdings (NASDAQ:EDTX) and Meten International Announce Successful Merger Closing and Capital Raise [ GlobeNewswire at 2020-03-30 12:25:00 ] BRIEF-Zentalis Pharmaceuticals Sees IPO Of Up To 7.65 Mln Shares ZENTALIS PHARMACEUTICALS : * ZENTALIS PHARMACEUTICALS LLC SEES IPO OF UP TO 7.65 MILLION SHARES OF COMMON STOCK PRICED TO BE BETWEEN $16.00 AND $18.00 PER SHARE - SEC FILING Source: [ Fidelity at 2020-03-30 04:55:13 ] Zentalis Pharmaceuticals sets IPO terms, to be valued at up to $592 million Zentalis Pharmaceuticals set terms of its initial public offering, in which the biopharmaceutical company developing cancer treatments is expected to raise up to $137.7 million. Zentalis is offering 7.65 million shares in the IPO, which is expected to price between $16 and $18 a share. That would give the company a market capitalization of up to $591.7 million. [ Fidelity at 2020-03-30 03:53:31 ] Shanghai tops world's IPO league table despite coronavirus Shanghai has topped global initial public offering league table for the first time in nearly three years, even as the coronavirus epidemic which originated in China rocked markets around the world. [ Fidelity at 2020-03-29 18:31:59 ] BRIEF-Loha Co Says Sees U.S. IPO Of Up To 4.3 Mln Class A Ordinary Shares Priced To Be Between $5.00 And $7.00 Per ... * LOHA CO LTD SAYS SEES U.S. IPO OF UP TO 4.3 MILLION CLASS A ORDINARY SHARES PRICED TO BE BETWEEN $5.00 AND $7.00 PER SHARE - SEC FILING. * LOHA CO LTD SAYS IT ADDS TIGER BROKERS, VALUABLE CAPITAL AND PRIME NUMBER CAPITAL ARE TO THE UNDERWRITERS TO THE IPO Source : Further company coverage: [ ] [ Fidelity at 2020-03-27 14:41:08 ] BRIEF-Hitek Global Sees U.S. IPO Of Up To 4.0 Mln Ordinary Shares Priced To Be Between $4 And $6 Per Share - SEC Filing Hitek Global Inc.: * HITEK GLOBAL INC SAYS NOW SEES U.S. IPO OF UP TO 4.0 MILLION ORDINARY SHARES PRICED TO BE BETWEEN $4 AND $6 PER ORDINARY SHARE - SEC FILING. * HITEK GLOBAL INC SAYS IT HAD PREVIOUSLY EXPECTED U.S. IPO OF UP TO 3.0 MILLION ORDINARY SHARES PRICED TO BE BETWEEN $4 AND $6 PER ORDINARY SHARE Source : Further company coverage: [ Fidelity at 2020-03-26 14:38:20 ] BRIEF-Gan Limited Files For U.S. IPO Of Up To $35 Million Gan Limited: * GAN LIMITED FILES FOR U.S. IPO OF UP TO $35 MILLION ORDINARY SHARES Â SEC FILING. * GAN LIMITED - HAVE APPLIED FOR LISTING OF ORDINARY SHARES ON THE NASDAQ CAPITAL MARKET UNDER THE SYMBOL ÂGAN. * GAN LIMITED - SAYS B. RILEY FBR IS UNDERWRITER TO IPO. * GAN LIMITED - PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR PURPOSE OF CALCULATING SEC REGISTRATION FEE Source text: [ Fidelity at 2020-03-25 10:01:32 ] SUSTAINABLE INFRASTRUCTURE DIVIDEND FUND IPO Raises $80 Million [ GlobeNewswire at 2020-03-25 06:14:00 ] Prudential Says Looking at Other Options Besides Minority IPO for Jackson Business; Shares Gain Shares of Prudential were up Tuesday morning after the insurance giant said it was considering other options besides a minority initial public offering for its US business, Jackson National Life, due to continued market turmoil caused by the ongoing COVID-19 pandemic. Earlier this month, the company said it was looking to float a minority stake in Jackson. [ Fidelity at 2020-03-24 06:41:37 ] BRIEF-Aura Announces Postponement Of Plans For Initial Public Offering And Listing In Brazil Amid COVID-19 Impact Aura Minerals Inc(ARMZF): * AURA ANNOUNCES POSTPONEMENT OF PLANS FOR INITIAL PUBLIC OFFERING AND LISTING IN BRAZIL AMID COVID-19 IMPACT. * Aura Minerals Inc(ARMZF) - WILL REASSESS MARKET CONDITIONS IN SECOND HALF OF 2020. * Aura Minerals Inc (ARMZF) - DECIDED TO POSTPONE INITIAL PUBLIC OFFERING IN BRAZIL AND CONCURRENT LISTING OF BRAZILIAN DEPOSITARY RECEIPTS ON B3 S.A. Source text for Eikon: Further company coverage: [ Fidelity at 2020-03-24 05:39:33 ] More IPO News >>